当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Frontiers in Pharmacology杂志
Frontiers in Pharmacology
基本信息
期刊名称 Frontiers in Pharmacology
FRONT PHARMACOL
期刊ISSN 1663-9812
期刊官方网站 https://www.frontiersin.org/journals/pharmacology
是否OA Yes
出版商 Frontiers Media SA
出版周期
文章处理费 登录后查看
始发年份
年文章数 2944
影响因子 4.4(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 PHARMACOLOGY & PHARMACY 药学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 7.8 1.066 0.999
Medicine
Pharmacology (medical)
41/272 85%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
76/313 75%
补充信息
自引率 4.5%
H-index 62
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1663-9812%5BISSN%5D
投稿指南
期刊投稿网址 https://www.frontiersin.org/submission/submit?domainid=1&fieldid=62&specialtyid=0&entitytype=2&entityid=176
收稿范围
Frontiers in Pharmacology is an interdisciplinary journal that publishes research on the interactions between drugs and living beings to prevent and cure human disease.

Led by Field Chief Editor Heike Wulff (University of California, Davis, US), Frontiers in Pharmacology explores basic and clinical pharmacology, medicinal chemistry, pharmacy, and toxicology to clarify the fundamental processes of disease treatment and drug effects. Indexed in PubMed Central (PMC), Scopus, Web of Science (SCIE), and the DOAJ, the journal welcomes academic, industrial, and clinical work focused on pharmacology.

Topics include, but are not limited to:

cardiovascular and smooth muscle pharmacology
drug metabolism and transport
drugs outcomes research and policies
ELSI in science and genetics
ethnopharmacology
experimental pharmacology and drug discovery
gastrointestinal and hepatic pharmacology
inflammation pharmacology
integrative and regenerative pharmacology
neuropharmacology
obstetric and pediatric pharmacology
pharmacoepidemiology
pharmacogenetics and pharmacogenomics
pharmacology of anti-cancer drugs
pharmacology of infectious diseases
pharmacology of ion channels and channelopathies
predictive toxicology
renal pharmacology
respiratory pharmacology
translational pharmacology.
All submissions to the journal involving natural products, including plant extracts or preparations, must adhere to 'The Four Pillars of Ethnopharmacology' to be considered for peer review, regardless of the specialty section, as a baseline standard for sample characterization. To be considered for publication in Frontiers in Pharmacology, studies incorporating complementary or alternative medicine must be based on a set of data linked to local or traditional uses that can be evaluated pharmacologically. A clear and plausible set of pharmacological data must be generated in these studies. Similarly, the journal endorses protocols including a minimum of two cell-lines in vitro as an evidential basis to demonstrate proposed anti-cancer effects in all relevant studies submitted to all specialty sections in the journal.

Further unique criteria for the conception and review of submissions may apply, where appropriate, for individual specialty sections.

The journal welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being.

Manuscripts that focus solely on clinical trials, patient management, or conventional therapies without a focus on pharmacological research are not suitable for publication in this journal. Additionally, studies that are purely statistical or predictive in nature, without providing novel insights into pharmacological mechanisms or drug development, are not within the scope of this journal.

Frontiers in Pharmacology is committed to advancing developments in the field of pharmacological discoveries by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future
收录体裁
投稿指南 https://www.frontiersin.org/journals/pharmacology/for-authors/author-guidelines
投稿模板
参考文献格式
编辑信息

                                
我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug